Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
Risk Signals
155 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Tekla Life Sciences Investors
Live alerts from global media, monitored by Business Radar
2023-11-30 (marketbeat.com)
Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P.
Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a
Read more
2023-10-09 (defenseworld.net)
Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC
RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Read more
2023-09-29 (marketbeat.com)
Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)
Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s
Read more
2022-11-02 (reporter.am)
Victory Capital Management Inc. Raises Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Victory Capital Management Inc. lifted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) by 7.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Read more